Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir vs Lamivudine for HBV Prophylaxis in Cancer Patients
NCT01580202Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- Apr 2012
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of entecavir in hepatitis B (HBV), sponsored by Seoul National University Hospital. Started Apr 2012; status: completed.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01580202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01580202.